Item 7.01 REGULATION FD DISCLOSURE

On September 2, 2020, H-Cyte, Inc. (the "Company") issued a press release extending their current rights offering until September 11, 2020. A copy of the press release is attached hereto and incorporated herein by reference as Exhibit 99.1

Item 9.01 Financial Statements and Exhibits





(d) Exhibits.



Exhibit Number   Description
99.1               Press Release dated September 2, 2020.

© Edgar Online, source Glimpses